PharmaBoardroom

The Ideal Pharma Country Manager: Mexico (Korn Ferry)

What traits, competencies and drivers do you need to be a successful pharma country manager in today's dynamic Mexican pharma market? Jose Guerrero…

The ‘Pharmacist’ Will See You Now

Meghann Chilcott, chief technology/marketing officer at Benzer Pharmacy provides insights for expanding point-of-care (POC) testing services in the US…

The Future of Cannabis and Cosmetics in Canada

In the light of several recent regulatory updates to Canada’s cannabis laws, lawyer Jean-Raphaël Champagne examines the potential for cannabis to…

A New Assessment Procedure for Reimbursable Medicines in…

Ruta Pumputiene examines recent regulatory reform in Lithuania, as the Baltic nation attempts to introduce a holistic HTA mechanism for the evaluation…

Fighting Corruption in Mexican Pharma

Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent…

Pharma Advertising on Social Media: In Need of a Regulatory…

Joana Silveira Botelho of Cuatrecasas argues for the need for an EU-wide regulatory update on the advertising of pharmaceutical products online, given…

Bridging Data Access Gaps to Drive Innovation in Biopharma

Tom Achoki of Mass Sciences explores the possibilities that better access to high-quality real-world data will create for accelerating novel drug…

The End of Free Sale of CBD Products in Europe?

Peter Homberg of Dentons Germany examines the regulatory status quo around the free sale of products containing cannabidiol (CBD) across Europe.…

The Novasecta Global 100: How Pharma Companies are Shaping the…

A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma companies are shaping the future of…

Top 100 Pharma Companies Shaping the Future of Healthcare…